Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Acrosyndromes (Raynaud's phenomenon and related disorders)

Internal medicine and immunology · Symptom or situation · updated 2026-10-30

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: Raynaud's phenomenon (the most common acrosyndrome): annual prevalence of 3.6% in women and 1.4% in men of a working population in the Pays de la Loire (2012) [1].

Suspected primary form

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Suspected scleroderma

Laboratory tests

Urine tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Second-line tests if the tests above are abnormal

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Erythromelalgia: look for a myeloproliferative neoplasm

Laboratory tests

If the FBC is normal: to be repeated regularly

Detailed explanation and international comparison (in French): read it in English (machine translation)

Also consider

Sources (14)
  1. Roquelaure Y, et al. Risk factors for Raynaud's phenomenon in the workforce. Arthritis Care Res (Hoboken). 2012;64:898-904.
  2. Belch J, Carlizza A, Carpentier PH, et al. ESVM guidelines – the diagnosis and management of Raynaud’s phenomenon. Vasa. 2017;46(6):413-23.
  3. Phénomène de Raynaud ou syndrome de Raynaud
  4. Ramahi A, Hughes M, Khanna D. Practical management of Raynaud’s phenomenon - a primer for practicing physicians. Curr Opin Rheumatol. 2022;34(4):235-44.
  5. Maverakis E, Patel F, Kronenberg DG, et al. International consensus criteria for the diagnosis of Raynaud’s phenomenon. J Autoimmun. 2014;48-49:60-5.
  6. National Health Service (Royaume-Uni). Raynaud’s (page d’information destinée aux patients, dernière révision le 20 juillet 2023), consultée le 30 octobre 2026.
  7. Pain CE, Constantin T, Toplak N, et al. Raynaud’s syndrome in children: systematic review and development of recommendations for assessment and monitoring (Paediatric Rheumatology European Society, groupe de travail sur la sclérodermie juvénile). Clin Exp Rheumatol. 2016;34 Suppl 100(5):200-6.
  8. Senet P. Diagnostic des acrosyndromes vasculaires. Ann Dermatol Venereol. 2015;142(8-9):513-8 (formation médicale continue, Société française de dermatologie).
  9. van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737-47.
  10. Miranda S, Le Besnerais M, Langlois V, Benhamou Y, Lévesque H. L'érythromélalgie : approche diagnostique et thérapeutique actuelle. Rev Med Interne. 2017;38(3):176-80.
  11. Kurzrock R, Cohen PR. Erythromelalgia and myeloproliferative disorders. Arch Intern Med. 1989;149(1):105-9.
  12. Michiels JJ, Abels J, Steketee J, van Vliet HH, Vuzevski VD. Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia. Ann Intern Med. 1985;102(4):466-71.
  13. Klein-Weigel PF, Volz TS, Richter JG. Erythromelalgia. Vasa. 2018;47(2):91-7.
  14. Tang Z, Chen Z, Tang B, Jiang H. Primary erythromelalgia: a review. Orphanet J Rare Dis. 2015;10:127.